IL2 and myeloid sarcoma: Blocking IL-2 + IL-12 had the same effect on Th-GM from MS patients but not on HCs, suggesting that IL-2 plays a key role in these effects (MS n = 8, Wilcoxon test p = 0.015; HC = 6, Wilcoxon test p = 0.43; Figure 7A,B).